Home/Filings/4/0001127602-24-015363
4//SEC Filing

Gayer Charles K 4

Accession 0001127602-24-015363

CIK 0000882796other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 7:04 AM ET

Size

4.3 KB

Accession

0001127602-24-015363

Insider Transaction Report

Form 4
Period: 2024-05-13
Gayer Charles K
Vice President and CCO
Transactions
  • Purchase

    Common Stock

    2024-05-13$5.47/sh+30,000$164,100307,533 total

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001800110

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:04 AM ET
Size
4.3 KB